Cell transplantation in Parkinson's disease: problems and perspectives
Laura E Allan1, Géraldine H Petit, Patrik Brundin
1Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund, Sweden.
Current Opinion in Neurology
|May 22, 2010
Summary
Cell therapy for Parkinson's disease shows promise with stem cells and direct reprogramming. New trials aim to improve clinical effectiveness and safety, addressing challenges like graft-induced dyskinesias.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stem Cell Biology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function.
- Current treatments like L-DOPA can cause dyskinesias.
- Cell transplantation is a potential therapeutic strategy for PD.
Purpose of the Study:
- Review recent experiments in embryonic tissue and stem cell transplants for PD models.
- Highlight challenges for clinical effectiveness and safety of cell therapy.
- Discuss advancements in generating dopaminergic neurons for transplantation.
Main Methods:
- Review of experimental models of Parkinson's disease using cell transplantation.
- Analysis of outcomes from previous clinical transplantation trials.
- Exploration of stem cell sources including human embryonic stem cells and induced pluripotent stem cells.
- Introduction to direct reprogramming of fibroblasts into neurons.
Main Results:
- Previous clinical trials showed variable motor recovery.
- Transplants may mitigate L-DOPA-induced dyskinesias, but graft-induced dyskinesias are a risk factor.
- Human embryonic stem cells and induced pluripotent stem cells offer alternative dopaminergic precursor sources.
- Direct reprogramming presents a novel method for neuron generation without pluripotency.
Conclusions:
- Cell transplantation for Parkinson's is advancing due to understanding graft-induced dyskinesias and new neuron generation methods.
- The Transeuro consortium's trials are expected to advance stem cell-based therapies for Parkinson's disease.
- Future trials may utilize stem cell-derived neurons for improved Parkinson's treatment.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...